{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:12:47Z","timestamp":1789665167828,"version":"4.0.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,3,19]],"date-time":"2012-03-19T00:00:00Z","timestamp":1332115200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Clin Pharmacol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1472-6904-12-8","type":"journal-article","created":{"date-parts":[[2012,3,19]],"date-time":"2012-03-19T15:14:25Z","timestamp":1332170065000},"source":"Crossref","is-referenced-by-count":28,"title":["Effect of exenatide on the pharmacokinetics of a combination oral contraceptive in healthy women: an open-label, randomised, crossover trial"],"prefix":"10.1186","volume":"12","author":[{"given":"Prajakti A","family":"Kothare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E","family":"Seger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Northrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Mace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm I","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helle","family":"Linnebjerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,3,19]]},"reference":[{"key":"129_CR1","first-page":"M1285","volume":"7","author":"S Reddy","year":"2005","unstructured":"Reddy S, Park S, Fineman M, Jay L, Carter M, Reynolds L, Sanburn N, Kothare PA: Clinical pharmacokinetics of exenatide in patients with type 2 diabetes [abstract]. AAPS J. 2005, 7: M1285-","journal-title":"AAPS J"},{"key":"129_CR2","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2174\/138920006776873490","volume":"7","author":"K Copley","year":"2006","unstructured":"Copley K, McCowen K, Hiles R, Nielsen LL, Young A, Parkes DG: Investigation of exenatide elimination and its in vivo and in vitro degradation. Curr Drug Metabol. 2006, 7: 367-374. 10.2174\/138920006776873490.","journal-title":"Curr Drug Metabol"},{"key":"129_CR3","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.1210\/jc.2002-021545","volume":"88","author":"OG Kolterman","year":"2003","unstructured":"Kolterman OG, Buse JB, Fineman MS, Gaines E, Heintz S, Bicsak TA, Taylor K, Kim D, Aisporna M, Wang Y, Baron AD: Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes. J Clin Endocrinol Metab. 2003, 88: 3082-3089. 10.1210\/jc.2002-021545.","journal-title":"J Clin Endocrinol Metab"},{"key":"129_CR4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/ajhp\/62.2.173","volume":"62","author":"OG Kolterman","year":"2005","unstructured":"Kolterman OG, Kim DD, Shen L, Ruggles JA, Nielsen LL, Fineman MS, Baron AD: Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus. Am J Health Syst Pharm. 2005, 62: 173-181.","journal-title":"Am J Health Syst Pharm"},{"key":"129_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.regpep.2008.07.003","volume":"151","author":"H Linnebjerg","year":"2008","unstructured":"Linnebjerg H, Park S, Kothare PA, Trautmann ME, Mace K, Fineman M, Wilding I, Nauck M, Horowitz M: Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes. Regul Pept. 2008, 151: 123-129. 10.1016\/j.regpep.2008.07.003.","journal-title":"Regul Pept"},{"key":"129_CR6","doi-asserted-by":"publisher","first-page":"4382","DOI":"10.1210\/jc.86.9.4382","volume":"86","author":"C Verdich","year":"2001","unstructured":"Verdich C, Flint A, Gutzwiller JP, N\u00e4slund E, Beglinger C, Hellstr\u00f6m PM, Long SJ, Morgan LM, Holst JJ, Astrup A: A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. J Clin Endocrinol Metab. 2001, 86: 4382-4389. 10.1210\/jc.86.9.4382.","journal-title":"J Clin Endocrinol Metab"},{"key":"129_CR7","doi-asserted-by":"crossref","first-page":"E155","DOI":"10.1152\/ajpendo.2001.281.1.E155","volume":"281","author":"CM Edwards","year":"2001","unstructured":"Edwards CM, Stanley SA, Davis R, Brynes AE, Frost GS, Seal LJ, Ghatei MA, Bloom SR: Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers. Am J Physiol Endocrinol Metab. 2001, 281: E155-E161.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"129_CR8","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1177\/0091270005278806","volume":"45","author":"PA Kothare","year":"2005","unstructured":"Kothare PA, Soon DK, Linnebjerg H, Park S, Chan C, Yeo A, Lim M, Mace KF, Wise SD: Effect of exenatide on the steady-state pharmacokinetics of digoxin. J Clin Pharmacol. 2005, 45: 1032-1037. 10.1177\/0091270005278806.","journal-title":"J Clin Pharmacol"},{"key":"129_CR9","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1177\/0091270006291622","volume":"46","author":"D Soon","year":"2006","unstructured":"Soon D, Kothare PA, Linnebjerg H, Park S, Yuen E, Mace KF, Wise SD: Effect of exenatide on the pharmacokinetics and pharmacodynamics of warfarin in healthy Asian men. J Clin Pharmacol. 2006, 46: 1179-1187. 10.1177\/0091270006291622.","journal-title":"J Clin Pharmacol"},{"key":"129_CR10","doi-asserted-by":"publisher","first-page":"114","DOI":"10.5414\/CPP45114","volume":"45","author":"PA Kothare","year":"2007","unstructured":"Kothare PA, Linnebjerg H, Skrivanek Z, Reddy S, Mace K, Pena A, Han J, Fineman M, Mitchell M: Exenatide effects on statin pharmacokinetics and lipid response. Int J Clin Pharmacol Ther. 2007, 45: 114-120.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"129_CR11","doi-asserted-by":"publisher","first-page":"651","DOI":"10.5414\/CPP47651","volume":"47","author":"H Linnebjerg","year":"2009","unstructured":"Linnebjerg H, Kothare P, Park S, Mace K, Mitchell M: The effect of exenatide on lisinopril pharmacodynamics and pharmacokinetics in patients with hypertension. Int J Clin Pharmacol Ther. 2009, 47: 651-658.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"129_CR12","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1177\/0091270004274432","volume":"45","author":"E Blase","year":"2005","unstructured":"Blase E, Taylor K, Gao HY, Wintle M, Fineman M: Pharmacokinetics of an oral drug (acetaminophen) administered at various times in relation to subcutaneous injection of exenatide (exendin-4) in healthy subjects. J Clin Pharmacol. 2005, 45: 570-577. 10.1177\/0091270004274432.","journal-title":"J Clin Pharmacol"},{"key":"129_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2165\/00003088-200746020-00003","volume":"46","author":"H Zhang","year":"2007","unstructured":"Zhang H, Cui D, Wang B, Han YH, Balimane P, Yang Z, Sinz M, Rodrigues AD: Pharmacokinetic drug interactions involving 17[alpha]-ethinylestradiol: a new look at an old drug. Clin Pharmacokinet. 2007, 46: 133-157. 10.2165\/00003088-200746020-00003.","journal-title":"Clin Pharmacokinet"},{"key":"129_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.contraception.2008.02.020","volume":"78","author":"JW Goldzieher","year":"2008","unstructured":"Goldzieher JW, Stanczyk FZ: Oral contraceptives and individual variability of circulating levels of ethinyl estradiol and progestins. Contraception. 2008, 78: 4-9. 10.1016\/j.contraception.2008.02.020.","journal-title":"Contraception"},{"key":"129_CR15","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.clpt.2003.08.009","volume":"74","author":"SD Hall","year":"2003","unstructured":"Hall SD, Wang Z, Huang SM, Hamman MA, Vasavada N, Adigun AQ, Hilligoss JK, Miller M, Gorski JC: The interaction between St John's wort and an oral contraceptive. Clin Pharmacol Ther. 2003, 74: 525-535. 10.1016\/j.clpt.2003.08.009.","journal-title":"Clin Pharmacol Ther"},{"key":"129_CR16","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1177\/0091270002239706","volume":"43","author":"RA Boyd","year":"2003","unstructured":"Boyd RA, Zegarac EA, Eldon MA: The effect of food on the bioavailability of norethindrone and ethinyl estradiol from norethindrone acetate\/ethinyl estradiol tablets intended for continuous hormone replacement therapy. J Clin Pharmacol. 2003, 43: 52-58. 10.1177\/0091270002239706.","journal-title":"J Clin Pharmacol"},{"key":"129_CR17","unstructured":"Byetta (package insert). 2008, San Diego, CA: Amylin Pharmaceuticals, Inc, [ http:\/\/documents.byetta.com\/Byetta_PI.pdf ]"},{"key":"129_CR18","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.2337\/diacare.27.11.2628","volume":"27","author":"JB Buse","year":"2004","unstructured":"Buse JB, Henry RR, Han J, Kim DD, Fineman MS, Baron AD: Exenatide-113 Clinical Study Group: Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes. Diabetes Care. 2004, 27: 2628-2635. 10.2337\/diacare.27.11.2628.","journal-title":"Diabetes Care"},{"key":"129_CR19","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.2337\/diacare.28.5.1092","volume":"28","author":"RA DeFronzo","year":"2005","unstructured":"DeFronzo RA, Ratner RE, Han J, Kim DD, Fineman MS, Baron AD: Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes. Diabetes Care. 2005, 28: 1092-1100. 10.2337\/diacare.28.5.1092.","journal-title":"Diabetes Care"},{"key":"129_CR20","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.2337\/diacare.28.5.1083","volume":"28","author":"DM Kendall","year":"2005","unstructured":"Kendall DM, Riddle MC, Rosenstock J, Zhuang D, Kim DD, Fineman MS, Baron AD: Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea. Diabetes Care. 2005, 28: 1083-1091. 10.2337\/diacare.28.5.1083.","journal-title":"Diabetes Care"},{"key":"129_CR21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1185\/030079908X253870","volume":"24","author":"DC Klonoff","year":"2008","unstructured":"Klonoff DC, Buse JB, Nielsen LL, Guan X, Bowlus CL, Holcombe JH, Wintle ME, Maggs DG: Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years. Curr Med Res Opin. 2008, 24: 275-286.","journal-title":"Curr Med Res Opin"},{"key":"129_CR22","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1001\/jama.284.23.3043","volume":"284","author":"World Medical Association Declaration of Helsinki","year":"2000","unstructured":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2000, 284: 3043-3045.","journal-title":"JAMA"},{"key":"129_CR23","unstructured":"Directive 2001\/20\/EC of the European Parliament and of the Council of 4 April 2001. The European Parliament and the Council of the European Union, [ http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/includes\/document\/document_detail.jsp?webContentId=WC500011204&murl=menus\/document_library\/document_library.jsp&mid=WC0b01ac058009a3dc ]"},{"key":"129_CR24","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jchromb.2005.01.012","volume":"825","author":"W Li","year":"2005","unstructured":"Li W, Li YH, Li AC, Zhou S, Naidong W: Simultaneous determination of norethindrone and ethinyl estradiol in human plasma by high performance liquid chromatography with tandem mass spectrometry-experiences on developing a highly selective method using derivatization reagent for enhancing sensitivity. J Chromatogr B Analyt Technol Biomed Life Sci. 2005, 825: 223-232. 10.1016\/j.jchromb.2005.01.012.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"}],"container-title":["BMC Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6904-12-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6904-12-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6904-12-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T16:27:44Z","timestamp":1561480064000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1186\/1472-6904-12-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,19]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["129"],"URL":"https:\/\/doi.org\/10.1186\/1472-6904-12-8","relation":{},"ISSN":["1472-6904"],"issn-type":[{"value":"1472-6904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,19]]},"article-number":"8"}}